154 related articles for article (PubMed ID: 36128344)
1. Transradial versus transfemoral arterial access in DEB-TACE for hepatocellular carcinoma.
Ghosh A; Gupta V; Al Khalifah A; Akhter NM
J Clin Imaging Sci; 2022; 12():38. PubMed ID: 36128344
[TBL] [Abstract][Full Text] [Related]
2. Transradial versus transfemoral arterial access in Yttrium-90 microspheres radioembolization for hepatocellular carcinoma.
Ghosh A; Zhang J; Akhter NM
J Clin Imaging Sci; 2022; 12():27. PubMed ID: 35673590
[TBL] [Abstract][Full Text] [Related]
3. Transradial versus transfemoral arterial access in the uterine artery embolization of fibroids.
Ghosh A; Agnihotri T; Gupta V; Sitwala P; Stanley M; Cai S; Akhter NM
Pol J Radiol; 2022; 87():e672-e677. PubMed ID: 36643011
[TBL] [Abstract][Full Text] [Related]
4. Transradial versus transfemoral access without closure device for transarterial chemoembolization in patients with hepatocellular carcinoma: a randomized trial.
Zhang X; Luo Y; Tsauo J; Zhao H; Gong T; Li J; Li Y; Zeng H; Sun W; Li X
Eur Radiol; 2022 Oct; 32(10):6812-6819. PubMed ID: 36018356
[TBL] [Abstract][Full Text] [Related]
5. Transradial versus transfemoral approach for TACE: a retrospective study.
You K; Guo T; Sun D; Song H; Liu Z
BMC Gastroenterol; 2023 Jan; 23(1):11. PubMed ID: 36631744
[TBL] [Abstract][Full Text] [Related]
6. Drug-eluting bead transarterial chemoembolization (TACE) exhibits superior efficacy and equal tolerance to conventional TACE in hepatocellular carcinoma patients with conventional TACE history.
Tang J; Huang Z; Xu J; Lv Q; Wang P
Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101814. PubMed ID: 34597848
[TBL] [Abstract][Full Text] [Related]
7. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
Wu B; Zhou J; Ling G; Zhu D; Long Q
World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
[TBL] [Abstract][Full Text] [Related]
8. Transradial access chemoembolization for hepatocellular carcinoma in comparation with transfemoral access.
Du N; Yang MJ; Ma JQ; Luo JJ; Zhang ZH; Yu TZ; Zheng ZY; Zhang W; Yan ZP
Transl Cancer Res; 2019 Sep; 8(5):1795-1805. PubMed ID: 35116930
[TBL] [Abstract][Full Text] [Related]
9. Operator radiation dose during trans-hepatic arterial chemoembolization: different patients' positions via transradial or transfemoral access.
Jiang H; Chen Y; Liao H; Gu Y; Meng X; Dong W
Diagn Interv Radiol; 2022 Jul; 28(4):376-382. PubMed ID: 35950283
[TBL] [Abstract][Full Text] [Related]
10. Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study.
Xing M; Webber G; Prajapati HJ; Chen Z; El-Rayes B; Spivey JR; Pillai AA; Kim HS
J Gastroenterol Hepatol; 2015 Jul; 30(7):1167-74. PubMed ID: 25675849
[TBL] [Abstract][Full Text] [Related]
11. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma.
Kang YJ; Lee BC; Kim JK; Yim NY; Kim HO; Cho SB; Jeong YY
Cardiovasc Intervent Radiol; 2020 Jan; 43(1):55-64. PubMed ID: 31646378
[TBL] [Abstract][Full Text] [Related]
12. Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Kloeckner R; Weinmann A; Prinz F; Pinto dos Santos D; Ruckes C; Dueber C; Pitton MB
BMC Cancer; 2015 Jun; 15():465. PubMed ID: 26059447
[TBL] [Abstract][Full Text] [Related]
13. Treatment efficacy and safety of drug-eluting beads transarterial chemoembolization versus conventional transarterial chemoembolization in hepatocellular carcinoma patients with arterioportal fistula.
Cai L; Li H; Guo J; Zhao W; Duan Y; Hou X; Cheng L; Du H; Shao X; Diao Z; Hao Y; Zheng X; Li C; Li W
Cancer Biol Ther; 2022 Dec; 23(1):89-95. PubMed ID: 35230928
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus
Ludwig JM; Zhang D; Xing M; Kim HS
Eur Radiol; 2017 May; 27(5):2031-2041. PubMed ID: 27562480
[TBL] [Abstract][Full Text] [Related]
15. Transradial arterial chemoembolization reduces complications and costs in patients with hepatocellular carcinoma.
Wu T; Sun R; Huang Y; Wang Z; Yin X; Zhu Z; Zhao Z; He J
Indian J Cancer; 2015 Dec; 52 Suppl 2():e107-11. PubMed ID: 26728666
[TBL] [Abstract][Full Text] [Related]
16. Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC.
Prajapati HJ; Xing M; Spivey JR; Hanish SI; El-Rayes BF; Kauh JS; Chen Z; Kim HS
AJR Am J Roentgenol; 2014 Dec; 203(6):W706-14. PubMed ID: 25415737
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of drug-eluting bead transarterial chemoembolization versus conventional transarterial chemoembolization for small hepatocellular carcinoma in Child-Pugh class A patients.
Lee IJ; Lee JH; Lee YB; Kim YJ; Yoon JH; Yin YH; Lee M; Hur S; Kim HC; Jae HJ; Chung JW
Ther Adv Med Oncol; 2019; 11():1758835919866072. PubMed ID: 31447948
[TBL] [Abstract][Full Text] [Related]
18. Safety and Long-Term Survival Outcome in Patients With Unresectable Barcelona Clinic Liver Cancer (BCLC) Stages C and D Advanced Hepatocellular Carcinoma Treated With 40 μm Drug-Eluting Bead Transcatheter Arterial Chemoembolization.
Wholey M; Palacios Iii R; Wholey D; Mendez A
Cureus; 2022 Apr; 14(4):e24047. PubMed ID: 35573558
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation.
Nicolini D; Svegliati-Baroni G; Candelari R; Mincarelli C; Mandolesi A; Bearzi I; Mocchegiani F; Vecchi A; Montalti R; Benedetti A; Risaliti A; Vivarelli M
World J Gastroenterol; 2013 Sep; 19(34):5622-32. PubMed ID: 24039354
[TBL] [Abstract][Full Text] [Related]
20. Short-term efficacy and safety of callispheres drug-loaded microsphere embolization in primary hepatocellular carcinoma.
Li J; Wang N; Shi C; Liu Q; Song J; Ye X
J Cancer Res Ther; 2021 Jul; 17(3):733-739. PubMed ID: 34269307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
